Related News

£10m awarded to partnership investigating innovative radiolabelled nanomedicines
Researchers at Barts Cancer Institute (BCI), Queen Mary University of London, will play a part in a revolutionary new partnership with King’s College London and the University of Leeds, aiming to accelerate and optimise the clinical translation of healthcare nanotechnologies.
General News 11 August 2025
